Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
CONCLUSION: The statins use reduced the risk of HCC recurrence after initial resection. Statins may have protective influences on HCC recurrence in patients who undergo initial liver resection.
PMID: 29081488 [PubMed - as supplied by publisher]
Source: BioScience Trends - Category: Biomedical Science Tags: Biosci Trends Source Type: research
More News: Biomedical Science | Cancer & Oncology | Carcinoma | Cholesterol | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Statin Therapy | Study | Urology & Nephrology